Literature DB >> 12186209

An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit.

Geir Bukholm1, Tone Tannaes, Anne Britt Bye Kjelsberg, Nils Smith-Erichsen.   

Abstract

OBJECTIVE: To investigate an outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit (ICU).
DESIGN: Epidemiologic investigation, environmental assessment, and ambidirectional cohort study.
SETTING: A secondary-care university hospital with a 10-bed ICU. PATIENTS: All patients admitted to the ICU receiving ventilator treatment from December 1, 1999, to September 1, 2000.
RESULTS: An outbreak in an ICU with multidrug-resistant isolates of P aeruginosa belonging to one amplified fragment-length polymorphism (AFLP)-defined genetic cluster was identified, characterized, and cleared. Molecular typing of bacterial isolates with AFLP made it possible to identify the outbreak and make rational decisions during the outbreak period. The outbreak included 19 patients during the study period. Infection with bacterial isolates belonging to the AFLP cluster was associated with reduced survival (odds ratio, 5.26; 95% confidence interval, 1.14 to 24.26). Enhanced barrier and hygiene precautions, cohorting of patients, and altered antibiotic policy were not sufficient to eliminate the outbreak. At the end of the study period (in July), there was a change in the outbreak pattern from long (December to June) to short (July) incubation times before colonization and from primarily tracheal colonization (December to June) to primarily gastric or enteral July) colonization. In this period, the bacterium was also isolated from water taps.
CONCLUSION: Complete elimination of the outbreak was achieved after weekly pasteurization of the water taps of the ICU and use of sterile water as a solvent in the gastric tubes.

Entities:  

Mesh:

Year:  2002        PMID: 12186209     DOI: 10.1086/502082

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  21 in total

1.  Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a non-intensive care unit surgical ward.

Authors:  Yoshio Takesue; Hiroki Ohge; Mitsuru Sakashita; Takeshi Sudo; Yoshiaki Murakami; Kenichiro Uemura; Taijiro Sueda
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Temporal and spatial diversity of the tap water microbiota in a Norwegian hospital.

Authors:  Knut Rudi; Tone Tannaes; Morten Vatn
Journal:  Appl Environ Microbiol       Date:  2009-10-16       Impact factor: 4.792

Review 3.  Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

Authors:  Marin H Kollef; Yoav Golan; Scott T Micek; Andrew F Shorr; Marcos I Restrepo
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

4.  Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.

Authors:  Laura H Rosenberger; Damien J LaPar; Robert G Sawyer
Journal:  J Am Coll Surg       Date:  2012-03-13       Impact factor: 6.113

5.  Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents.

Authors:  Tomefa E Asempa; David P Nicolau; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

6.  Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.

Authors:  James A Karlowsky; Deborah C Draghi; Mark E Jones; Clyde Thornsberry; Ian R Friedland; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 7.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

8.  Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa.

Authors:  A Deplano; O Denis; L Poirel; D Hocquet; C Nonhoff; B Byl; P Nordmann; J L Vincent; M J Struelens
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.

Authors:  M Montero; J P Horcajada; L Sorlí; F Alvarez-Lerma; S Grau; M Riu; M Sala; H Knobel
Journal:  Infection       Date:  2009-06-04       Impact factor: 3.553

10.  Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy.

Authors:  Laura Pagani; Elisabetta Mantengoli; Roberta Migliavacca; Elisabetta Nucleo; Simona Pollini; Melissa Spalla; Rossana Daturi; Egidio Romero; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.